Back to top
more

Harrow, Inc. (HROW)

(Delayed Data from NSDQ)

$10.32 USD

10.32
661,080

-0.36 (-3.37%)

Updated Apr 23, 2024 04:00 PM ET

After-Market: $10.32 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (147 out of 252)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

New Strong Sell Stocks for November 14th

AKZOY, GTX and HROW have been added to the Zacks Rank #5 (Strong Sell) List on November 14, 2023.

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 4.41% and 2.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Harrow (HROW): Can Its 17.8% Jump Turn into More Strength?

Harrow (HROW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Harrow Health (HROW) Gains As Market Dips: What You Should Know

Harrow Health (HROW) closed at $18.72 in the latest trading session, marking a +1.99% move from the prior day.

Harrow Health (HROW) Outpaces Stock Market Gains: What You Should Know

Harrow Health (HROW) closed the most recent trading day at $17.91, moving +0.73% from the previous trading session.

Harrow Health (HROW) Flat As Market Sinks: What You Should Know

Harrow Health (HROW) closed at $18.52 in the latest trading session, marking no change from the prior day.

Harrow Health (HROW) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Harrow Health (HROW) closed at $18.68, marking a -1.01% move from the previous day.

Shrabana Mukherjee headshot

Analysts Initiate Coverage: 5 Stocks for Higher Returns

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like MicroStrategy (MSTR), SPX Technologies (SPXC), Cvent (CVT), Harrow Health (HROW) and Banco (BMA).

Harrow Health (HROW) Reports Q1 Loss, Tops Revenue Estimates

Harrow (HROW) delivered earnings and revenue surprises of 50% and 0.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 33.33% and 1.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Harrow Health (HROW) to Report Q1 Earnings: What's in the Offing?

Harrow Health's (HROW) first-quarter top line is likely to have been driven by its recent product launches.

Zacks.com featured highlights Arcellx, Harrow Health, PROG, Chipotle Mexican Grill and Meta

Arcellx, Harrow Health, PROG, Chipotle Mexican Grill and Meta have been highlighted in this Screen of The Week article.

Nalak Das headshot

5 Stocks With Recent Price Strength That Still Have Upside

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are META, CMG, ACLX, HROW and PRG.

Benjamin Rains headshot

Use New Analyst Coverage to Find Great Momentum Stocks to Buy in May

One way for investors to find potentially market-beating stocks to buy in May is to search for stocks gaining analyst coverage.

Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?

Here is how HCA Healthcare (HCA) and Harrow Health (HROW) have performed compared to their sector so far this year.

Here's Why Momentum in Harrow (HROW) Should Keep going

Harrow (HROW) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Harrow Health (HROW) Stock Sinks As Market Gains: What You Should Know

Harrow Health (HROW) closed at $25.23 in the latest trading session, marking a -0.63% move from the prior day.

Zacks.com featured highlights Harrow Health and Disc Medicine Opco

Harrow Health and Disc Medicine Opco have been highlighted in this Screen of The Week article.

Shrabana Mukherjee headshot

2 Stocks in Focus as Analysts Initiate Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Harrow Health (HROW) and Disc Medicine (IRON).

Harrow Health and CDW have been highlighted as Zacks Bull and Bear of the Day

Harrow Health and CDW have been highlighted as Zacks Bull and Bear of the Day.

Brian Bolan headshot

Bull Of The Day: Harrow Health (HROW)

This "roll up" play is expected to post some good growth this year as well as next.

Nalak Das headshot

5 Small Hidden Gems to Pick From a Rangebound Wall Street

We have narrowed our search to five stocks that have provided more than 50% returns year to date with more upside left. These are: CRD.A, REPX, UVE, ASUR and HROW.

Harrow Health (HROW) Dips More Than Broader Markets: What You Should Know

Harrow Health (HROW) closed the most recent trading day at $23.50, moving -0.63% from the previous trading session.

Zacks.com featured highlights include Riley Exploration Permian, Harrow Health, Crawford, Tecnoglass and Lantheus Holdings

Riley Exploration Permian, Harrow Health, Crawford, Tecnoglass and Lantheus Holdings are part of the Zacks Screen of the Week article.

Nalak Das headshot

5 Stocks With Recent Price Strength to Maximize Your Gains

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are TGLS, CRD.B, REPX, HROW and LNTH.